Triazolyl pyridyl benzenesulfonamides as CCR2 or CCR9 modulators for the treatment of atherosclerosis

Details for Australian Patent Application No. 2007272972 (hide)

Owner ChemoCentryx, Inc.

Inventors Jin, Jeff; Pennell, Andrew M.K.; Punna, Sreenivas; Charvat, Trevor T.; Zeng, Yibin; Melikian, Anita; Hu, Cheng; Ungashe, Solomon; Li, Yandong

Agent Spruson & Ferguson

Pub. Number AU-B-2007272972

PCT Pub. Number WO2008/008375

Priority 60/945,854 22.06.07 US; 60/831,042 14.07.06 US

Filing date 10 July 2007

Wipo publication date 17 January 2008

Acceptance publication date 1 December 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

5 February 2009 PCT application entered the National Phase

  PCT publication WO2008/008375 Priority application(s): WO2008/008375

1 December 2011 Application Accepted

  Published as AU-B-2007272972

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007272981-Papilla spreader

2007272970-Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors